Biomarkers May Predict TKI Response In Metastatic RCC

Angiogenesis-related biomarkers regulated by hypoxia were found to be strong predictors of primary renal tumor response (PRT), progression-free survival (PFS), and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) who were being treated with sunitinib prior to kidney removal, according to research published in Clinical Cancer Research.108/08/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news